StockData
Impact BioMedical Inc. logo

Impact BioMedical Inc. (IBO) stock

IBONYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 6/30
$3.06+0.38 (+14.18%)

Close on Oct 19, 2026Market cap $329.93MP/E –Yield –

Impact BioMedical price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Impact BioMedical's price to sales ratio was 112.2× on Aug 31, 2026.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Aug 31, 2026112.2×–

More Impact BioMedical figures

See a number that looks wrong?